Drug & Market Development Productions has released a new market report entitled Commercial Opportunities in RNA Interference — The Emerging Revolution.
The report, said D&MD, includes assessments of the projected market impact of RNAi through 2008, the commercial opportunities for using related technologies, those in the industry, the patenting of RNAi, and the technical aspects of the technology.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
